Christopher Williams Archive — Page 1 of 2
-
February 4, 2021
Potential biomarker for IBD severity, cancer risk identified
A selenium transport protein produced in the colon may be a novel biomarker for assessing disease severity and cancer risk in patients with inflammatory bowel disease. -
April 16, 2020
Medical Scientist Training Program adapts to COVID-19 challenges
The Medical Scientist Training Program has been intentional in approaching the challenges presented by COVID-19. -
February 28, 2019
Protein loss promotes cell migration
The protein kinase STK17A plays a novel role in epithelial cells and its loss may contribute to colorectal cancer invasion and metastasis, Vanderbilt researchers report. -
July 19, 2018
Novel insights on “leaky” gut
A protein involved in binding cells together helps maintain the integrity of the intestinal mucosa and plays a protective role in ulcerative colitis. -
June 21, 2018
Burroughs Wellcome Fund award expands opportunities for physician-scientists
Vanderbilt University has received a five-year, $2.5-million Physician Scientist Institutional Award from the Burroughs Wellcome Fund to help bolster the dwindling number of active physician-scientists in the United States. -
May 19, 2016
Williams to lead physician-scientist training program
Christopher Williams, M.D., Ph.D., associate professor of Medicine and Cancer Biology, was recently named associate dean for Vanderbilt University School of Medicine’s Physician-Scientist Education and Training Program (PSTP) and director of the Medical Science Training Program (MSTP). -
February 11, 2016
Study identifies potential colon cancer biomarker
A protein that suppresses a key cancer pathway in the colon may be a potential biomarker for colitis-associated tumors, researchers at Vanderbilt University Medical Center reported last month in the journal Gut.